Global Hepatitis A Vaccine Market Insights, Forecast to 2029
Table of Contents1 Study Coverage
1.1 Hepatitis A Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Hepatitis A Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Inactivated Vaccine
1.2.3 Live Attenuated Vaccine
1.3 Market by Application
1.3.1 Global Hepatitis A Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Hepatitis A Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Hepatitis A Vaccine Revenue by Region
2.2.1 Global Hepatitis A Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Hepatitis A Vaccine Revenue by Region (2018-2023)
2.2.3 Global Hepatitis A Vaccine Revenue by Region (2024-2029)
2.2.4 Global Hepatitis A Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Hepatitis A Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Hepatitis A Vaccine Sales by Region
2.4.1 Global Hepatitis A Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Hepatitis A Vaccine Sales by Region (2018-2023)
2.4.3 Global Hepatitis A Vaccine Sales by Region (2024-2029)
2.4.4 Global Hepatitis A Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Hepatitis A Vaccine Sales by Manufacturers
3.1.1 Global Hepatitis A Vaccine Sales by Manufacturers (2018-2023)
3.1.2 Global Hepatitis A Vaccine Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hepatitis A Vaccine in 2022
3.2 Global Hepatitis A Vaccine Revenue by Manufacturers
3.2.1 Global Hepatitis A Vaccine Revenue by Manufacturers (2018-2023)
3.2.2 Global Hepatitis A Vaccine Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Hepatitis A Vaccine Revenue in 2022
3.3 Global Key Players of Hepatitis A Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Hepatitis A Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Hepatitis A Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Hepatitis A Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Hepatitis A Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Hepatitis A Vaccine Sales by Type
4.1.1 Global Hepatitis A Vaccine Historical Sales by Type (2018-2023)
4.1.2 Global Hepatitis A Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Hepatitis A Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Hepatitis A Vaccine Revenue by Type
4.2.1 Global Hepatitis A Vaccine Historical Revenue by Type (2018-2023)
4.2.2 Global Hepatitis A Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Hepatitis A Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Hepatitis A Vaccine Price by Type
4.3.1 Global Hepatitis A Vaccine Price by Type (2018-2023)
4.3.2 Global Hepatitis A Vaccine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Hepatitis A Vaccine Sales by Application
5.1.1 Global Hepatitis A Vaccine Historical Sales by Application (2018-2023)
5.1.2 Global Hepatitis A Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Hepatitis A Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Hepatitis A Vaccine Revenue by Application
5.2.1 Global Hepatitis A Vaccine Historical Revenue by Application (2018-2023)
5.2.2 Global Hepatitis A Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Hepatitis A Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Hepatitis A Vaccine Price by Application
5.3.1 Global Hepatitis A Vaccine Price by Application (2018-2023)
5.3.2 Global Hepatitis A Vaccine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Hepatitis A Vaccine Market Size by Type
6.1.1 US & Canada Hepatitis A Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Hepatitis A Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Hepatitis A Vaccine Market Size by Application
6.2.1 US & Canada Hepatitis A Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Hepatitis A Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Hepatitis A Vaccine Market Size by Country
6.3.1 US & Canada Hepatitis A Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Hepatitis A Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Hepatitis A Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Hepatitis A Vaccine Market Size by Type
7.1.1 Europe Hepatitis A Vaccine Sales by Type (2018-2029)
7.1.2 Europe Hepatitis A Vaccine Revenue by Type (2018-2029)
7.2 Europe Hepatitis A Vaccine Market Size by Application
7.2.1 Europe Hepatitis A Vaccine Sales by Application (2018-2029)
7.2.2 Europe Hepatitis A Vaccine Revenue by Application (2018-2029)
7.3 Europe Hepatitis A Vaccine Market Size by Country
7.3.1 Europe Hepatitis A Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Hepatitis A Vaccine Sales by Country (2018-2029)
7.3.3 Europe Hepatitis A Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Hepatitis A Vaccine Market Size
8.1.1 China Hepatitis A Vaccine Sales (2018-2029)
8.1.2 China Hepatitis A Vaccine Revenue (2018-2029)
8.2 China Hepatitis A Vaccine Market Size by Application
8.2.1 China Hepatitis A Vaccine Sales by Application (2018-2029)
8.2.2 China Hepatitis A Vaccine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Hepatitis A Vaccine Market Size by Type
9.1.1 Asia Hepatitis A Vaccine Sales by Type (2018-2029)
9.1.2 Asia Hepatitis A Vaccine Revenue by Type (2018-2029)
9.2 Asia Hepatitis A Vaccine Market Size by Application
9.2.1 Asia Hepatitis A Vaccine Sales by Application (2018-2029)
9.2.2 Asia Hepatitis A Vaccine Revenue by Application (2018-2029)
9.3 Asia Hepatitis A Vaccine Sales by Region
9.3.1 Asia Hepatitis A Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Hepatitis A Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Hepatitis A Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Hepatitis A Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Hepatitis A Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Hepatitis A Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Hepatitis A Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Hepatitis A Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Hepatitis A Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Hepatitis A Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Hepatitis A Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Hepatitis A Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Hepatitis A Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 GSK
11.1.1 GSK Company Information
11.1.2 GSK Overview
11.1.3 GSK Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 GSK Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GSK Recent Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Overview
11.2.3 Merck Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Merck Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Sanofi Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Recent Developments
11.4 Sinovac
11.4.1 Sinovac Company Information
11.4.2 Sinovac Overview
11.4.3 Sinovac Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Sinovac Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sinovac Recent Developments
11.5 Zhejiang Pukang
11.5.1 Zhejiang Pukang Company Information
11.5.2 Zhejiang Pukang Overview
11.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Zhejiang Pukang Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Zhejiang Pukang Recent Developments
11.6 Changchun Institute of Biological
11.6.1 Changchun Institute of Biological Company Information
11.6.2 Changchun Institute of Biological Overview
11.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Changchun Institute of Biological Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Changchun Institute of Biological Recent Developments
11.7 KM Biologics
11.7.1 KM Biologics Company Information
11.7.2 KM Biologics Overview
11.7.3 KM Biologics Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 KM Biologics Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 KM Biologics Recent Developments
11.8 IMBCAMS
11.8.1 IMBCAMS Company Information
11.8.2 IMBCAMS Overview
11.8.3 IMBCAMS Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 IMBCAMS Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 IMBCAMS Recent Developments
11.9 Convac
11.9.1 Convac Company Information
11.9.2 Convac Overview
11.9.3 Convac Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Convac Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Convac Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Hepatitis A Vaccine Industry Chain Analysis
12.2 Hepatitis A Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hepatitis A Vaccine Production Mode & Process
12.4 Hepatitis A Vaccine Sales and Marketing
12.4.1 Hepatitis A Vaccine Sales Channels
12.4.2 Hepatitis A Vaccine Distributors
12.5 Hepatitis A Vaccine Customers
13 Market Dynamics
13.1 Hepatitis A Vaccine Industry Trends
13.2 Hepatitis A Vaccine Market Drivers
13.3 Hepatitis A Vaccine Market Challenges
13.4 Hepatitis A Vaccine Market Restraints
14 Key Findings in The Global Hepatitis A Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of TablesTable 1. Global Hepatitis A Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Inactivated Vaccine
Table 3. Major Manufacturers of Live Attenuated Vaccine
Table 4. Global Hepatitis A Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Hepatitis A Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Hepatitis A Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Hepatitis A Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Hepatitis A Vaccine Revenue Market Share by Region (2018-2023)
Table 9. Global Hepatitis A Vaccine Revenue Market Share by Region (2024-2029)
Table 10. Global Hepatitis A Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Hepatitis A Vaccine Sales by Region (2018-2023) & (K Unit)
Table 12. Global Hepatitis A Vaccine Sales by Region (2024-2029) & (K Unit)
Table 13. Global Hepatitis A Vaccine Sales Market Share by Region (2018-2023)
Table 14. Global Hepatitis A Vaccine Sales Market Share by Region (2024-2029)
Table 15. Global Hepatitis A Vaccine Sales by Manufacturers (2018-2023) & (K Unit)
Table 16. Global Hepatitis A Vaccine Sales Share by Manufacturers (2018-2023)
Table 17. Global Hepatitis A Vaccine Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Hepatitis A Vaccine Revenue Share by Manufacturers (2018-2023)
Table 19. Global Key Players of Hepatitis A Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
Table 20. Hepatitis A Vaccine Price by Manufacturers 2018-2023 (USD/Unit)
Table 21. Global Hepatitis A Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Hepatitis A Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis A Vaccine as of 2022)
Table 23. Global Key Manufacturers of Hepatitis A Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Hepatitis A Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Hepatitis A Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Hepatitis A Vaccine Sales by Type (2018-2023) & (K Unit)
Table 28. Global Hepatitis A Vaccine Sales by Type (2024-2029) & (K Unit)
Table 29. Global Hepatitis A Vaccine Sales Share by Type (2018-2023)
Table 30. Global Hepatitis A Vaccine Sales Share by Type (2024-2029)
Table 31. Global Hepatitis A Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Hepatitis A Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Hepatitis A Vaccine Revenue Share by Type (2018-2023)
Table 34. Global Hepatitis A Vaccine Revenue Share by Type (2024-2029)
Table 35. Hepatitis A Vaccine Price by Type (2018-2023) & (USD/Unit)
Table 36. Global Hepatitis A Vaccine Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Hepatitis A Vaccine Sales by Application (2018-2023) & (K Unit)
Table 38. Global Hepatitis A Vaccine Sales by Application (2024-2029) & (K Unit)
Table 39. Global Hepatitis A Vaccine Sales Share by Application (2018-2023)
Table 40. Global Hepatitis A Vaccine Sales Share by Application (2024-2029)
Table 41. Global Hepatitis A Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Hepatitis A Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Hepatitis A Vaccine Revenue Share by Application (2018-2023)
Table 44. Global Hepatitis A Vaccine Revenue Share by Application (2024-2029)
Table 45. Hepatitis A Vaccine Price by Application (2018-2023) & (USD/Unit)
Table 46. Global Hepatitis A Vaccine Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Hepatitis A Vaccine Sales by Type (2018-2023) & (K Unit)
Table 48. US & Canada Hepatitis A Vaccine Sales by Type (2024-2029) & (K Unit)
Table 49. US & Canada Hepatitis A Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 50. US & Canada Hepatitis A Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Hepatitis A Vaccine Sales by Application (2018-2023) & (K Unit)
Table 52. US & Canada Hepatitis A Vaccine Sales by Application (2024-2029) & (K Unit)
Table 53. US & Canada Hepatitis A Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 54. US & Canada Hepatitis A Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Hepatitis A Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Hepatitis A Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 57. US & Canada Hepatitis A Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Hepatitis A Vaccine Sales by Country (2018-2023) & (K Unit)
Table 59. US & Canada Hepatitis A Vaccine Sales by Country (2024-2029) & (K Unit)
Table 60. Europe Hepatitis A Vaccine Sales by Type (2018-2023) & (K Unit)
Table 61. Europe Hepatitis A Vaccine Sales by Type (2024-2029) & (K Unit)
Table 62. Europe Hepatitis A Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 63. Europe Hepatitis A Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Hepatitis A Vaccine Sales by Application (2018-2023) & (K Unit)
Table 65. Europe Hepatitis A Vaccine Sales by Application (2024-2029) & (K Unit)
Table 66. Europe Hepatitis A Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 67. Europe Hepatitis A Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Hepatitis A Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Hepatitis A Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 70. Europe Hepatitis A Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Hepatitis A Vaccine Sales by Country (2018-2023) & (K Unit)
Table 72. Europe Hepatitis A Vaccine Sales by Country (2024-2029) & (K Unit)
Table 73. China Hepatitis A Vaccine Sales by Type (2018-2023) & (K Unit)
Table 74. China Hepatitis A Vaccine Sales by Type (2024-2029) & (K Unit)
Table 75. China Hepatitis A Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 76. China Hepatitis A Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Hepatitis A Vaccine Sales by Application (2018-2023) & (K Unit)
Table 78. China Hepatitis A Vaccine Sales by Application (2024-2029) & (K Unit)
Table 79. China Hepatitis A Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 80. China Hepatitis A Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Hepatitis A Vaccine Sales by Type (2018-2023) & (K Unit)
Table 82. Asia Hepatitis A Vaccine Sales by Type (2024-2029) & (K Unit)
Table 83. Asia Hepatitis A Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 84. Asia Hepatitis A Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Hepatitis A Vaccine Sales by Application (2018-2023) & (K Unit)
Table 86. Asia Hepatitis A Vaccine Sales by Application (2024-2029) & (K Unit)
Table 87. Asia Hepatitis A Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 88. Asia Hepatitis A Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Hepatitis A Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Hepatitis A Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 91. Asia Hepatitis A Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Hepatitis A Vaccine Sales by Region (2018-2023) & (K Unit)
Table 93. Asia Hepatitis A Vaccine Sales by Region (2024-2029) & (K Unit)
Table 94. Middle East, Africa and Latin America Hepatitis A Vaccine Sales by Type (2018-2023) & (K Unit)
Table 95. Middle East, Africa and Latin America Hepatitis A Vaccine Sales by Type (2024-2029) & (K Unit)
Table 96. Middle East, Africa and Latin America Hepatitis A Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 97. Middle East, Africa and Latin America Hepatitis A Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Hepatitis A Vaccine Sales by Application (2018-2023) & (K Unit)
Table 99. Middle East, Africa and Latin America Hepatitis A Vaccine Sales by Application (2024-2029) & (K Unit)
Table 100. Middle East, Africa and Latin America Hepatitis A Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 101. Middle East, Africa and Latin America Hepatitis A Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Hepatitis A Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Hepatitis A Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Hepatitis A Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Hepatitis A Vaccine Sales by Country (2018-2023) & (K Unit)
Table 106. Middle East, Africa and Latin America Hepatitis A Vaccine Sales by Country (2024-2029) & (K Unit)
Table 107. GSK Company Information
Table 108. GSK Description and Major Businesses
Table 109. GSK Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 110. GSK Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. GSK Recent Developments
Table 112. Merck Company Information
Table 113. Merck Description and Major Businesses
Table 114. Merck Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 115. Merck Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Merck Recent Developments
Table 117. Sanofi Company Information
Table 118. Sanofi Description and Major Businesses
Table 119. Sanofi Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 120. Sanofi Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Sanofi Recent Developments
Table 122. Sinovac Company Information
Table 123. Sinovac Description and Major Businesses
Table 124. Sinovac Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 125. Sinovac Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Sinovac Recent Developments
Table 127. Zhejiang Pukang Company Information
Table 128. Zhejiang Pukang Description and Major Businesses
Table 129. Zhejiang Pukang Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 130. Zhejiang Pukang Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Zhejiang Pukang Recent Developments
Table 132. Changchun Institute of Biological Company Information
Table 133. Changchun Institute of Biological Description and Major Businesses
Table 134. Changchun Institute of Biological Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 135. Changchun Institute of Biological Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Changchun Institute of Biological Recent Developments
Table 137. KM Biologics Company Information
Table 138. KM Biologics Description and Major Businesses
Table 139. KM Biologics Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 140. KM Biologics Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. KM Biologics Recent Developments
Table 142. IMBCAMS Company Information
Table 143. IMBCAMS Description and Major Businesses
Table 144. IMBCAMS Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 145. IMBCAMS Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. IMBCAMS Recent Developments
Table 147. Convac Company Information
Table 148. Convac Description and Major Businesses
Table 149. Convac Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 150. Convac Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Convac Recent Developments
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Hepatitis A Vaccine Distributors List
Table 155. Hepatitis A Vaccine Customers List
Table 156. Hepatitis A Vaccine Market Trends
Table 157. Hepatitis A Vaccine Market Drivers
Table 158. Hepatitis A Vaccine Market Challenges
Table 159. Hepatitis A Vaccine Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of FiguresFigure 1. Hepatitis A Vaccine Product Picture
Figure 2. Global Hepatitis A Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Hepatitis A Vaccine Market Share by Type in 2022 & 2029
Figure 4. Inactivated Vaccine Product Picture
Figure 5. Live Attenuated Vaccine Product Picture
Figure 6. Global Hepatitis A Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Hepatitis A Vaccine Market Share by Application in 2022 & 2029
Figure 8. Government Institution
Figure 9. Private Sector
Figure 10. Other
Figure 11. Hepatitis A Vaccine Report Years Considered
Figure 12. Global Hepatitis A Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Hepatitis A Vaccine Revenue 2018-2029 (US$ Million)
Figure 14. Global Hepatitis A Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Hepatitis A Vaccine Revenue Market Share by Region (2018-2029)
Figure 16. Global Hepatitis A Vaccine Sales 2018-2029 ((K Unit)
Figure 17. Global Hepatitis A Vaccine Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Hepatitis A Vaccine Sales YoY (2018-2029) & (K Unit)
Figure 19. US & Canada Hepatitis A Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Hepatitis A Vaccine Sales YoY (2018-2029) & (K Unit)
Figure 21. Europe Hepatitis A Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Hepatitis A Vaccine Sales YoY (2018-2029) & (K Unit)
Figure 23. China Hepatitis A Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Hepatitis A Vaccine Sales YoY (2018-2029) & (K Unit)
Figure 25. Asia (excluding China) Hepatitis A Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Hepatitis A Vaccine Sales YoY (2018-2029) & (K Unit)
Figure 27. Middle East, Africa and Latin America Hepatitis A Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Hepatitis A Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Hepatitis A Vaccine in the World: Market Share by Hepatitis A Vaccine Revenue in 2022
Figure 30. Global Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Hepatitis A Vaccine Sales Market Share by Type (2018-2029)
Figure 32. Global Hepatitis A Vaccine Revenue Market Share by Type (2018-2029)
Figure 33. Global Hepatitis A Vaccine Sales Market Share by Application (2018-2029)
Figure 34. Global Hepatitis A Vaccine Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Hepatitis A Vaccine Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Hepatitis A Vaccine Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Hepatitis A Vaccine Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Hepatitis A Vaccine Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Hepatitis A Vaccine Revenue Share by Country (2018-2029)
Figure 40. US & Canada Hepatitis A Vaccine Sales Share by Country (2018-2029)
Figure 41. U.S. Hepatitis A Vaccine Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Hepatitis A Vaccine Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Hepatitis A Vaccine Sales Market Share by Type (2018-2029)
Figure 44. Europe Hepatitis A Vaccine Revenue Market Share by Type (2018-2029)
Figure 45. Europe Hepatitis A Vaccine Sales Market Share by Application (2018-2029)
Figure 46. Europe Hepatitis A Vaccine Revenue Market Share by Application (2018-2029)
Figure 47. Europe Hepatitis A Vaccine Revenue Share by Country (2018-2029)
Figure 48. Europe Hepatitis A Vaccine Sales Share by Country (2018-2029)
Figure 49. Germany Hepatitis A Vaccine Revenue (2018-2029) & (US$ Million)
Figure 50. France Hepatitis A Vaccine Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Hepatitis A Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Hepatitis A Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Hepatitis A Vaccine Revenue (2018-2029) & (US$ Million)
Figure 54. China Hepatitis A Vaccine Sales Market Share by Type (2018-2029)
Figure 55. China Hepatitis A Vaccine Revenue Market Share by Type (2018-2029)
Figure 56. China Hepatitis A Vaccine Sales Market Share by Application (2018-2029)
Figure 57. China Hepatitis A Vaccine Revenue Market Share by Application (2018-2029)
Figure 58. Asia Hepatitis A Vaccine Sales Market Share by Type (2018-2029)
Figure 59. Asia Hepatitis A Vaccine Revenue Market Share by Type (2018-2029)
Figure 60. Asia Hepatitis A Vaccine Sales Market Share by Application (2018-2029)
Figure 61. Asia Hepatitis A Vaccine Revenue Market Share by Application (2018-2029)
Figure 62. Asia Hepatitis A Vaccine Revenue Share by Region (2018-2029)
Figure 63. Asia Hepatitis A Vaccine Sales Share by Region (2018-2029)
Figure 64. Japan Hepatitis A Vaccine Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Hepatitis A Vaccine Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Hepatitis A Vaccine Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Hepatitis A Vaccine Revenue (2018-2029) & (US$ Million)
Figure 68. India Hepatitis A Vaccine Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Hepatitis A Vaccine Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Hepatitis A Vaccine Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Hepatitis A V